FC Patch Comparator Study

PHASE3CompletedINTERVENTIONAL
Enrollment

422

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Contraception
Interventions
DRUG

BAY86-5016, SH P00331F

Drug amount per patch: 0.9 mg EE2 + 1.9 mg gestodene (GSD)

DRUG

SH P00331N

Drug amount per patch: 0.6 mg EE2 + 6 mg NGM

Trial Locations (28)

1030

Vienna

1090

Vienna

6300

Wörgl

6900

Bregenz

8010

Graz

8740

Zeltweg

11100

San Fernando

15701

Santiago de Compostela

17190

Salt

19002

Guadalajara

20100

Turku

20541

Turku

31500

Toulouse

33000

Bordeaux

36002

Pontevedra

42300

Roanne

45200

Montargis

54042

Nancy

60200

Compiègne

60204

Compiègne

64200

Biarritz

75018

Paris

78100

Saint-Germain-en-Laye

78600

Maisons Lafitte

93500

Pantin

00100

Helsinki

00180

Helsinki

08006

Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY